Drinking Regular Milk Tied to Higher Heart Disease Risk in Women

Translate to Spanish or other 102 languages!

Regular milk consumption may have a negative effect on heart health in women, but fermented milk products appear to be safe. Image for illustration purposes
Regular milk consumption may have a negative effect on heart health in women, but fermented milk products appear to be safe. Image for illustration purposes
- Advertisement -
  • Researchers recently studied how consuming fermented and nonfermented milk may impact heart disease in men and women. 
  • Fermented milk, also known as cultured milk, undergoes a process to add beneficial bacteria, yeast, or acids. 
  • The study found that taking in higher amounts of non-fermented milk is associated with a higher risk of ischemic heart disease (also called coronary heart diseaseand myocardial infarction (heart attack) in women. 
  • While nonfermented milk was associated with a higher risk of these heart issues in women, the study did not find a negative impact on heart disease in men.

A recent study involving around 100,000 Swedish women and men examined how milk consumption impacts cardiometabolic proteins. Doctors use these protein patterns to determine someone’s risk for cardiovascular disease.

Follow the link below to Medical News today to read the full story:

https://www.medicalnewstoday.com/articles/drinking-regular-milk-tied-to-higher-heart-disease-risk-in-women

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Physicians Warn of Rising ER Visits Linked to E-Bikes and Scooters

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...
- Advertisement -